Related Experiment Video
Updated: Jun 9, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Severity Profile of COVID-19 in Hospitalized Pediatric Patients
Vânia Chagas da Costa1,2, Ulisses Ramos Montarroyos1, Katiuscia Araújo de Miranda Lopes2
1Postgraduate Program in Health Sciences, Universidade de Pernambuco, Recife 50100-010, Pernambuco, Brazil.
Insights
Children hospitalized with COVID-19 face severe illness risks, especially those with uncontrolled asthma, obesity, cough, or under one year old. Improved asthma and nutrition management are crucial for these pediatric patients.
Area of Science:
- Pediatric Infectious Diseases
- Epidemiology
- Public Health
Background:
- COVID-19 significantly impacts pediatric populations, necessitating understanding of disease severity factors.
- Hospitalized children with COVID-19 require detailed clinical characterization to guide management.
Purpose of the Study:
- To identify clinical characteristics associated with severe COVID-19 outcomes in hospitalized children.
- To analyze risk factors contributing to severe disease in pediatric COVID-19 cases.
Main Methods:
- An epidemiological cohort study involving 191 children aged 0-14 years hospitalized with COVID-19 between March 2020 and June 2021.
- Data collected from hospital epidemiology centers and medical records, classifying severity as severe (critical/severe) or non-severe (asymptomatic/mild/moderate).
- Multivariate analysis used to determine the association between clinical profile and disease severity.
Main Results:
- 73.3% of hospitalized children developed severe COVID-19.
- Hypoxemia (oxygen saturation <95%) was observed in 46.6% of cases.
- Risk factors for severe COVID-19 included uncontrolled asthma (RR=13.2), overweight/obesity (RR=3.21), cough (RR=2.72), and age under one year (RR=3.23).
Conclusions:
- Children with uncontrolled asthma, overweight/obesity, cough, or under one year old are at higher risk for severe COVID-19.
- Highlights the need for enhanced healthcare, particularly in managing asthma and nutrition, for vulnerable pediatric COVID-19 patients.
Objective:
We aimed to describe the clinical characteristics associated with severity in children hospitalized with COVID-19.
Method:
This was an epidemiological cohort study conducted in two hospitals, one of which was a reference center for the treatment of COVID-19 cases. Data were collected from the reports generated by the hospital epidemiology centers and the medical records of patients aged between 0 and 14 years with a diagnosis of COVID-19, hospitalized between March 2020 and June 2021. To analyze the association between the clinical profile and severity, the cases were classified as severe (severe and critical) and non-severe (asymptomatic, mild, and moderate).
Results:
Of the 191 children followed up in the cohort, 73.3% developed the severe form. The percentage of children with oxygen saturation below 95% was 46.6%. In the multivariate analysis, a higher risk of severity was estimated among children with uncontrolled asthma (RR = 13.2), who were overweight or obese (RR = 3.21), who had cough symptoms (RR = 2.72), and those aged under one year (RR = 3.23).
Conclusions:
This result underscores the need to improve healthcare at every level for children and for the management of asthma and nutrition when considering children with this clinical profile who are diagnosed with COVID-19.
More Related Videos
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
11:27A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Respiratory Failure-IV
Pneumonia III: Complications and Assessment
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia II: Pathophysiology